Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Nishant Shah

Preventive Cardiology · Duke Hospital

View

Dr. Amit Khera

Preventive Cardiology · UT Southwestern

View

Dr. Martha Gulati

Preventive Cardiology · Houston Methodist

View

Dr. Pradeep Natarajan

Preventive Cardiology · MGH

View

Dr. Christopher Cannon

Preventive Cardiology · BWH

View

Dr. Nicholas Marston

Preventive Cardiology · BWH

View

Dr. Dorairaj Prabhakaran

General Cardiology

View

Dr. Pugazhendhi Vijayaraman

EP · Geisinger

View

Dr. Robert Schaller

EP · HUP

View

Dr. Trey Woods

General Cardiology · Emory Healthcare

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    High-Density Lipoprotein Lipid and Protein Cargo and Cholesterol Efflux Capacity Before and After Bariatric Surgery.

    Jan 2, 2025DOI: 10.1161/atvbaha.124.321686Comparative StudyAHA

    Written by: Sohail ZahidFlorencia SchlampMichael A GildeaBing-Xue LinAriya ChaloemtoemMarcin FalisManish ParikhEdward A FisherThorsten HornemannTomas VaisarSean P Heffron

    Find these authors on Roon

    SZ
    Dr. Sohail Zahid
    Preventive Cardiology · Johns Hopkins

    Introduction

    Obesity is a chronic, multifactorial disease that contributes to the pathogenesis of many conditions including cardiovascular disease (CVD), diabetes, and cancer.1 Obesity is characterized by low levels of high-density lipoprotein (HDL) cholesterol and impaired HDL function.2–4 HDL’s participation in cholesterol efflux, the removal of cholesterol from the periphery, including atherosclerotic plaques, has been considered to be the predominant mechanism for its well-known inverse association with CVD risk.5–7 Measures of this function – cholesterol efflux capacity (CEC) – ex vivo have demonstrated inverse associations with incident cardiovascular events.5, 6 HDL particles carry hundreds of different proteins and lipids, many of which are not just passive cargo but are biologically active in a diversity of functions such as cholesterol homeostasis, vascular inflammation, and thrombosis.8, 9 In different diseases, such as coronary artery disease or diabetes, the distribution of HDL protein and lipid cargo is altered and may impact various atheroprotective functions of HDL in these conditions.10, 11Bariatric surgery is one of the most effective treatments for severe obesity.12 Two procedures constitute 96% of all bariatric surgeries performed worldwide – Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG).13 Both procedures are associated with significantly reduced cardiovascular events and mortality,14, 15 as well as improvements in cardiovascular risk factors, including blood pressure, lipid profiles, insulin sensitivity and systemic inflammation.12, 14, 16–18 While weight loss contributes to these improvements, bariatric surgery leads to weight-loss independent improvements in cardiovascular disease risk,19, 20 thought to arise through multiple mechanisms including changes in incretin and bile acid signaling, gut microbiome, vascular function, and adipokine secretion.20 Bariatric surgery also induces significant changes in HDL function and CEC, but the mechanisms underlying these changes are not well understood.21–23This study sought to determine the effects of RYGB and SG on HDL protein and lipid cargo and investigate potential associations with changes in CEC.

    Methods

    Because of the sensitive nature of the data collected for this study, the data that support the findings of this study are available from the corresponding author upon reasonable request from qualified researchers trained in human subject confidentiality.Premenopausal Hispanic women with severe obesity between the ages of 18 and 55 undergoing either RYGB or SG at Bellevue Hospital Center (New York, NY), the largest public safety-net hospital in New York City, were recruited for a prospective observational study approved by the NYU School of Medicine and the New York Health and Hospitals Institutional Review Board. The singular ethnicity and gender were chosen because of their high prevalence (>85%) within the population. The decision as to which procedure was performed was made by the patient after consultation with the attending surgeon. Patients were excluded if they were active smokers, receiving lipid-lowering agents, diabetes medications, thyroid hormone, or oral contraceptives, had polycystic ovary syndrome, or if they became pregnant during the study. 109 participants fulfilled enrollment criteria and consented to participate in this study. 74 women (41 SG, 33 RYGB) presented for baseline anthropometric and blood testing and underwent surgery, 67 (36 SG, 31 RYGB) attended the six-month postoperative visit, and 55 (32 SG, 23 RYGB) the 12-month follow-up visit. A flow chart describing the inclusion, exclusion, and dropout of participants is outlined in Supplementary Figure S1. At pre-operative, and six-month and twelve-month postoperative intervals, patients underwent clinical and blood testing. This study was approved by the NYU School of Medicine Institutional Review Board and was performed in accordance with the Declaration of Helsinki ethical standards.At each time point, plasma was isolated from patient blood samples and submitted to HDL proteomic and lipidomic analysis according to previously validated methods, adhering to the guidelines for DIA proteomics and lipidomics data reporting.2, 11, 24, 25 Briefly, plasma was subjected to sequential ultracentrifugation to isolate HDL,2, 26 and for proteomic analyses, isolated HDL underwent proteolytic digestion, and data independent analysis (DIA) LC-MS/MS analysis.27 Lipids were quantified in isolated HDL by direct flow injection electrospray ionization-tandem LC-MS/MS.11, 24 QC filtering (slope > 0, R2 > 0.5, and coefficient of variation < 0.5) reduced the number of lipids from 629 to obtain 266 distinct HDL lipids. HDL particle concentration was quantified using a differential ion mobility analyzer and characterized as small ~8 nm, medium ~9 nm, and large ~11.1 nm, as previously described.28 Further details of the methods for HDL proteomics and lipidomics analysis are available in the supplementary methods.2, 25, 29–37Cholesterol efflux capacity of apoB-depleted serum (“serum HDL”) was quantified via a validated high-throughput method, at Vascular Strategies LLC (Plymouth Meeting, USA). CEC from J774A.1 cells exposed to cAMP is termed ‘global CEC’ and that from cells not exposed to cAMP ‘non-ABCA1 CEC.’ The difference between global and non-ABCA1 CEC is termed ‘cAMP-inducible CEC’ or ‘ABCA1 CEC’ largely representing efflux via ABCA1-mediate pathway. Further details of the methods for HDL CEC calculation are available in the supplementary methods.7, 24, 38Statistical analyses were performed using the R software package (https://cran.r-project.org/).Patients underwent clinical, anthropometric, and blood sampling (from which HDL proteomic and lipidomic measurements were made) at pre-operative and six-month and twelve- month postoperative visits. Baseline characteristics of surgical groups were compared using independent sample t-tests or Wilcoxon rank sum tests for continuous variables and chi-square analyses for categorical variables. Within each group, post-operative percent changes from pre-operative values of clinical variables and normalized CEC were calculated and compared via paired-samples t-tests. For HDL-associated lipid and proteins, the log2 Fold Change in median normalized concentrations of each analyte between pre-operative and six-month and 12-month postoperative samples was determined for each surgical group. For each comparison, an FDR of 0.05 were considered statistically significant. Hierarchical clustering was used to group proteins and lipids based on similarity in concentration changes (measured in log2 Fold Change of the medians) after RYGB and SG.39 Mediation analyses between changes in proteins, lipids and CEC included measurements at pre-operative and six-month and twelve-month postoperative intervals and were conducted using the methods of Tingley et al.40 Sensitivity analyses of the mediation effect of HDL protein and lipid changes on CEC were completed according to previously reported methods employed by Imai et al.41 Longitudinal associations of each individual protein or lipid present on HDL particles with ABCA1, non-ABCA1, and global CEC at the individual participant level were measured using a linear mixed-effect model with FDR correction.

    Results

    Sixty-seven participants (SG, n = 36; RYGB, n = 31) underwent surgery and returned for the 6-month follow-up visit. Participants were young (32.7 ± 8.0 years), severely obese (BMI of 43.8 ± 6.4 kg/m2), and (as it was exclusionary) were not taking any medications for insulin resistance/diabetes or dyslipidemia. Although participants undergoing SG were statistically significantly older, there were no other differences in baseline characteristics between surgical groups (Table 1). Fifty-five participants (SG, n = 32, RYGB, n = 23) also returned for the 12-month follow-up visit.Both surgical procedures resulted in similar reductions in BMI, waist circumference, and triglycerides at 6 months (Table S1). At 6 months, participants who underwent RYGB experienced a statistically significant decrease in global and ABCA1 CEC. Participants who underwent SG exhibited no significant changes in global or ABCA1 CEC, but significantly increased non-ABCA1 CEC (Table S2). At 12 months, there was a statistically significant increase in non-ABCA1 CEC from baseline following both RYGB and SG (Table S2). There were no statistically significant differences in global, ABCA1, or non-ABCA1 CEC at 12 months between RYGB and SG. Further details about the effects of SG and RYGB on CEC in study participants are found in our earlier publication.21We performed quantitative analysis of 75 HDL-associated proteins and 266 HDL-associated lipids (Table S3). Amounts of 29 of these proteins on HDL were significantly altered after RYGB, 33 after SG, and 47 total after at least one surgery. Sixty-nine lipids carried on HDL experienced statistically significant changes in their concentrations after RYGB, 74 after SG, and 150 after at least one of the two procedures (Table S3).Figures 1 and 2 display heat maps representing the proteins (34 increased, 13 decreased) and lipids (71 increased, 79 decreased) that changed significantly from before to 6 and/or 12 months after each surgery, respectively. The proteins with greatest relative increases from before surgery were BPIFB1, GPLD1, PON3, PLTP, and HPR, whereas those that were most reduced were SAA1, SAA2, APOL1, SERPINF1, and PPBP (Figure 1, Table S4, proteins listed in descending order of relative change magnitude). Following bariatric surgery, HDL content of large chain phosphatidylcholines (PCs) and lysophosphatidylcholines (LPCs) increased while smaller chain PCs, phosphatidylethanolamines (PEs), triglycerides (TGs) and phosphatidylinositols (PIs) decreased. The largest relative increases were observed in PC (44:1), LPC (24:5), and PC (44:12) with the greatest reductions in PI (32:1), PE (40:3), and LPI (16:1). There were several lipids that exhibited contrasting changes in content at 6 months depending upon surgical procedure (Figure 2, Table S5), including t20:0, d18:0, and LPC (20:4). Participants with severe obesity had distinct HDL protein (Figure S2) and lipid profiles (Figure S3) compared to controls with normal body mass index from the same outpatient population (n=8) before bariatric surgery, but had more similar profiles 6 and 12 months after surgery.We applied hierarchical clustering to identify all HDL proteins that exhibited similar profiles of change following surgery (Table S6). Dendrograms annotating the cluster membership of HDL proteins and lipids based on cluster distance and height are shown in Figures S3 and S4. There were 15 clusters of HDL proteins (5 increased, 5 decreased, 5 minimal change) and 25 clusters of HDL lipids (7 increased, 11 decreased, 7 minimal change) with similar patterns of aggregate change following bariatric surgery. Box plots of HDL proteins and lipids with increased, decreased, and minimal change following bariatric surgery are displayed in Figures 3, 4, and S6, respectively. Cluster 39 [LC (24:5), PC (42:3), PC (44:5), PC (46:5)] was the only significant lipid or protein cluster that exhibited differing responses between RYGB and SG (Figure S4). The lipids in cluster 39 were in similar quantity at baseline between RYGB and SG, but increased more after RYGB compared to SG, and were in significantly greater concentrations on HDL particles in all participants at 12 months after their procedures.After bariatric surgery, concentrations of small HDL particles significantly decreased, medium HDL particles were unchanged, and large HDL particles significantly increased (Figure S5). Specific HDL protein and lipid clusters were significantly associated with small, medium, or large HDL particle sizes (Table S7). 7 out of 15 HDL protein clusters were associated with small HDL particles. These same clusters were oppositely associated with concentrations of large HDL particles. There were an additional 3 out of 15 and 2 out of 15 HDL protein clusters independently associated with small and large HDL particles respectively. 8 out of 25 HDL lipid clusters were associated with concentrations of small HDL particles and medium/large HDL particles in the opposite direction. An additional 2 out of 25 and 3 out of 25 HDL lipid clusters were independently associated with concentrations of small and large HDL particles respectively.Table S8 displays the longitudinal associations of each individual protein or lipid present on HDL particles with ABCA1, non-ABCA1, and global CEC at the individual participant level were measured using a linear mixed-effect model with FDR correction. There were 0, 5, and 1 HDL proteins positively associated and 0, 9, and 7 HDL proteins negatively associated with ABCA1, non-ABCA1, and global CEC, respectively. There were 6, 54, and 49 HDL lipids positively associated and 1, 28, and 23 HDL lipids negatively associated with ABCA1, non-ABCA1, and global CEC, respectively.We performed mediation analyses to assess whether changes in clusters of proteins and/or lipids on HDL following bariatric surgery could partly explain changes in ex vivo CEC. Figure 5A demonstrates the possible interactions between surgeries, proteins, lipids, and CEC. For example, HDL proteins and lipids can directly mediate the causal pathway between surgery and CEC, be affected through reverse causation mediated by altered post-operative CEC, or be confounded by other unmeasured variables.Figure 5B displays HDL cargo clusters suggested to mediate changes in ABCA1 and non-ABCA1 CEC following either RYGB, SG, or both surgeries, whereas Figure 5C shows the HDL lipid clusters affected by reverse causation mediated by post-operative cholesterol efflux. Cluster 12 [HP, HPR, CLU, PLTP, PON3, AGT] had the strongest influence on ABCA1 CEC – suggested to mediate 71.8% of bariatric surgery’s effect on ABCA1 CEC. The cluster with the strongest influence on non-ABCA1 CEC was cluster 38 [Cer (m42:1), PC (42:1), PC (44:12), PC (44:4)] – estimated to mediate 27.6% of bariatric surgery’s effect on non-ABCA1 CEC. There were no HDL lipid clusters suggested to be affected by reverse causation from ABCA1 CEC. Non-ABCA1 CEC significantly mediated the effect on cluster 38 and cluster 40 [(PC (44:1)]. The cluster most influenced by reverse causation via non-ABCA1 CEC was cluster 38, for which 17.3% of bariatric surgery’s effect on this cluster was mediated by non-ABCA1 CEC.Sensitivity analyses showed that the average causal mediated effects of HDL protein and lipid clusters contributing to ABCA1 or non-ABCA1 CEC were not significantly impacted by varying sensitivity parameters (Figure S9).From the aforementioned mediation analyses, we constructed interaction network diagrams to outline the impact of bariatric surgery on HDL protein/lipid cargo and ABCA1 and non-ABCA1 CEC (Figure 6A and 6B). Bariatric surgery is associated with an early reduction in ABCA1 CEC which analyses suggested is mediated through changes in the contents of clusters 2 [APOL1], 19 [PE (38:3)], and 21 [PC (31:1), PC (36:5), PC (36:6), PC (38:3), PE (34:0)] (decreases) and clusters 12 [HP, HPR, CLU, PLTP, PON3, AGT], 14 [GPLD1], and 15 [BPIFB1] (increases). In contrast, bariatric surgery is associated with increased non-ABCA1 CEC that is suggested to be mediated through cluster 38 [Cer (m42:1), PC (42:1), PC (44:12), PC (44:4)], which also increases post-operatively. PC (44:1) (cluster 40) was suggested to increase in response to increased post-operative non-ABCA1 cholesterol efflux.Figure 7 displays differences between RYGB and SG in HDL protein/lipid and CEC interaction networks. RYGB was associated with decreased ABCA1 CEC mediated through increased amounts of BPIFB1 (cluster 15). RYGB-associated increases in 12-month post-op non-ABCA1 CEC was suggested to be mediated by reductions in APOL1 (cluster 2) and lipids in clusters 23 [AcCa (13:1), AcCa (8:1), d18:2P, m17:0, PC (34:2), PC (36:4), TG (52:2), TG (52:3), TG (52:4), TG (54:5)] and increases in lipids in clusters 38 and 40 [Cer (m42:1), PC (42:1), PC (44:12), PC (44:4), PC (44:1)]. Following RYGB, increased non-ABCA1 CEC mediated increased amounts of lipids in clusters 30 [LPC (15:1), LPE (18:1), PC (34:1), PC (37:4), PC (38:1), PC (38:5), PC (40:7), PC (40:8), PC (42:5)] and 38 on HDL particles. The association of SG and ABCA1 CEC was mediated through increased amounts of cargo from clusters 12 and 39 [LPC (24:5), PC (42:3), PC (44:5), PC (46:5)]. Following SG, increased non-ABCA1 CEC mediated increases in the amounts of PC (39:2), PC (40:3), PC (42:6) (cluster 33) carried on HDL.Ex vivo CEC has repeatedly been shown to exhibit positive correlations with levels of plasma triglycerides and HDL particle size.21, 42–44 We thus examined the longitudinal associations of both plasma triglycerides and HDL particle size with each individual HDL-carried protein or lipid at the individual participant level using a linear mixed-effect model, displayed in Table S9 and S10. There were 7 proteins and 58 lipids positively associated and 12 proteins and 28 lipids negatively associated with HDL particle size, respectively. There were 14 lipids and 1 protein positively associated and 19 lipids and 18 proteins negatively associated with plasma triglyceride levels, respectively. Plasma triglycerides and small HDL particles significantly mediated the effect of bariatric surgery on ABCA1 and non-ABCA1 CEC; whereas medium, large, or overall HDL particle size was not found to mediate CEC (Figure S10).

    Discussion

    We report the largest and longest study of HDL protein and lipid cargo following bariatric surgery. We found that after surgery:Concentrations of 47 proteins carried on HDL changed (34 increased, 13 decreased) and changes could be grouped into 15 clusters (five increased, five decreased, five minimal change).Concentrations of 150 lipids carried on HDL changed (71 increased, 79 decreased) and could be grouped into 25 clusters (seven increased, eleven decreased, seven minimal change).Changes occurring in several of these protein and lipid clusters may mediate changes in HDL function in CEC after bariatric surgery.HDL consists of a complex family of lipids and proteins, whose individual subspecies are involved in a host of protective activities such as cholesterol transport, cell communication to maintain endothelial integrity, and inactivation of biohazards.8, 45 However, HDL may lose its protective capacity and actually gain deleterious functions in the setting of chronic disease (e.g. diabetes, chronic kidney disease, and coronary artery disease).42, 45–47 There are very limited data on the effects of obesity or bariatric surgery on the HDL proteome/lipidome or cholesterol efflux. Previous studies have shown that obesity leads to an altered HDL proteomic and lipidomic profile that is pro-inflammatory, contributes to insulin resistance, and impairs CEC.45, 48 Conversely, weight loss has been shown to “normalize” the HDL proteomic and lipidomic profile and enhance CEC.22, 23 To our knowledge, our study is the first to investigate the impact of bariatric surgery on the HDL proteome and lipidome.We found that concentrations of 47 proteins changed significantly following bariatric surgery. Several of these alterations are consistent with previous reports of the HDL proteome in obesity and metabolic syndrome. For example, others have reported that in these conditions, HDL is enriched in serum amyloid A proteins (SAA1 and SAA2) and deficient in clusterin (CLU), APO4, APOD, APOE, APOF, APOM, and paroxonase 3 (PON3).11, 49 In our study, we found that the concentrations of HDL-associated proteins deficient in obesity increased following both RYGB and SG.Obesity and metabolic syndrome are also associated with an abnormal HDL lipid profile, with high concentrations of TGs, oxidized fatty acids (FAs), PCs, and decreased content of LPCs, sphingomyelins (SMs), and cholesterol esters (CEs).49–52 This is consistent with our findings that bariatric surgery and its associated weight loss was associated with a significantly modified HDL lipid cargo characterized by increased large chain PCs and LPCs and decreased small chain PCs, PEs, TGs, and PIs.11, 49, 52 Previous HDL lipidomic studies have shown that levels of individual CEs, PCs, PEs, ceramides (CERs) and TGs are independently associated with cardiovascular disease.53–56 These lipids were significantly decreased on HDL particles following both RYGB and SG, suggesting a potential link between bariatric surgery and improved cardiovascular outcomes through modification of the HDL lipidome.57Mediation analyses performed in this study suggest that post-operative changes in several HDL protein and lipid clusters were partly responsible for changes in ABCA1- and non-ABCA1 CEC, and varied by procedure. Several of the proteins and lipids within these clusters have known associations with CEC, consistent with our observations. For example, reverse cholesterol transport has been shown to be inhibited when HDL carries greater amounts of haptoglobins (HP and HPR),58 CLU,59 PON3,59 and phospholipid transfer protein (PLTP).60, 61 In our study, changes in APOL1 had a positive correlation with post-operative changes in ABCA1-CEC and a negative correlation with changes in non-ABCA1-CEC. Previous studies suggest that aberrant APOL1 variants are associated with decreased HDL cholesterol content, decreased cholesterol efflux and lower ABCA1-CEC,62 but the impact of APOL1 on non-ABCA1 CEC was heretofore unknown.In our study, some clusters of PCs and PIs carried on HDL were suggested to mediate post-operative changes in ABCA1 CEC while other clusters of PCs and ceramides influenced non-ABCA1 CEC. The phospholipid composition of HDL has been shown to be a major determinant of CEC. The surface rigidity of HDL particles – determined by the proportions of SM and FCs in the lipid monolayer of the particles63, 64 – influences their capacity to further accept cholesterol. Previous studies have shown that modifications in HDL phospholipids can affect both ABCA1 and non-ABCA1 CEC.65, 66 For example, PC enrichment have been shown to increase the cholesterol efflux of cholesterol while SMs decrease the influx.67 To the best of our knowledge, our study is the first to describe a directional mediation relationship between specific lipid groups with ABCA1-CEC and non-ABCA1-CEC after bariatric surgery.We found several groups of lipids carried on HDL exhibited contrasting responses following the two surgeries investigated in this study. HDL from patients undergoing RYGB exhibited greater relative increases in lipids from a cluster composed of PCs and LPCs, relative to SG. The HDL lipid cluster concentration was similar at baseline between the two surgical groups, started to diverge at 6 months, and became significantly different at 12 months. Although both surgeries achieve rapid and consistent weight loss, RYGB and SG differ substantially in regard to the anatomical alterations characterizing each procedure and differences in metabolic changes between the two surgeries are not fully known. Roux-en-Y gastric bypass involves the creation of a small proximal gastric pouch anastomosed to the jejunum, thus bypassing the distal stomach and proximal small bowel. Sleeve gastrectomy consists of the removal of the gastric fundus without any anastomoses. Previous studies have shown that RYGB and SG produce contrasting effects on cholesterol content and efflux.21 Through the removal of the duodenum and proximal component of the jejunum, RYGB impairs the emulsification, hydrolysis, and micellization of fats, notably decreasing the digestion and absorption of TGs and phospholipids.68 Additionally, RYGB increases circulating bile acids that modulate effects of circulating lipids such as reducing triglyceride content and APOA1 expression via agonism of the Farsenoid X receptor.20, 69 Due to the shorter conduit between the stomach and jejunum, RYGB is thought to result in greater amounts of GLP-1 and GIP agonism,70 which leads to decreased postprandial TGs, apolipoprotein B concentrations, and hepatic FA storage, thus modifying the lipid-lipoprotein profile.71 In contrast, SG also has been shown to increase PPARα, which upregulates ApoA1 production, suppresses ApoA1 turnover, and increases CEC.72Our analyses suggested that several HDL-associated proteins that were affected by bariatric surgery may mediate changes in CEC that were also observed post-operatively – BPIFB1 and GPLD1. BPIFB1, belongs to the bactericidal/permeability-increasing-fold containing family and is an immune protection molecule with functions spanning bacterial and virus inhibition, respiratory epithelium protection, and suppression of gastric tumors through its binding of lipopolysaccharide groups.73 While one shotgun HDL proteomics study indicated that BPIFB1 is enriched in patients with cholesterol ester transfer protein deficiency,74 the mechanisms underlying the role of this HDL-associated protein in obesity and CEC are unclear. In our study, there was no significant association between CETP and BPIFB1 levels in patients before and after bariatric surgery. GPLD1 hydrolyzes glycan-phosphatidylinositol (GPI) linkages of GPI-anchored proteins and regulates their activity. While GPLD1 has been suggested to have roles in improving oral glucose tolerance, reducing serum triglyceride catabolism,75 increasing insulin sensitivity,76, 77 and enhancing HDL’s ability to inhibit the apoptosis of endothelial cells,11 its role in CEC is unknown. In Cardner et al.’s analysis of patients with diabetes and coronary artery disease, GLPD1 was not shown to be significantly associated with CEC.11 Further studies are needed to assess the roles of these HDL-associated proteins in cholesterol efflux.

    Limitations

    Our study has several limitations. Assignment to undergo a particular surgical procedure performed was not random. However, the only statistically significant difference in preoperative characteristics between the two groups was a clinically insignificant difference in age. In addition, our study sample consisted of a relatively homogenous population. This was done intentionally in order to reduce confounding in our small sample. As a result, we cannot confidently extrapolate our findings to other groups, such as older patients, other races, men, or individuals with diabetes. However, many of the changes in the HDL proteome and lipidome in our study are similar to those found in previous publications in patients with diabetes or coronary artery disease.11In our study we did not find a statistically significant association between APOA1 content on HDL particles and ABCA1 or non-ABCA1-CEC. APOA1 is well known to be a key mediator of cholesterol efflux, particularly ABCA1-mediated cholesterol efflux.78 There may be several explanations for our observation. Our study assessed normalized APOA1 concentrations per individual HDL particle, whereas CEC assessments were made with apoB-depleted serum and values not corrected for APOA1 or HDL concentrations in serum. Another potential explanation is that post-translational modifications of APOA1, such as oxidation or nitration78 (which were not assessed in this study), could have a greater impact on CEC than coincident changes in APOA1 concentration on HDL particles.Another limitation in our study is the modest sample size for HDL proteomic and lipidomic and mediation analyses. A sample size of 55 participants achieves 80% power to detect a mediation effect of at least 37.9% using a two-sided significance level of 0.05 and assuming a correlation of at least 0.35 between bariatric surgery and changes in HDL protein/lipid clusters. Further studies with larger sample sizes are needed to assess whether the changes we found to the HDL proteome and lipidome after bariatric surgery are consistent in other populations and diseases. Nonetheless, our study constitutes the largest investigation of HDL protein and lipid cargo after bariatric surgery as previous large scale HDL proteomics and lipidomics studies often enrolled fewer than 50 participants.79

    Conclusion

    We report the largest proteomic and lipidomic analysis of HDL in obesity and following bariatric surgery and suggest potential impact of the changes we observe on HDL function in CEC. We found that concentrations of a number of proteins and lipids with established roles in the pathophysiology of atherosclerotic cardiovascular disease were significantly altered. These changes may mediate the improved CVD risk observed in obesity individuals who undergo bariatric surgery.
    SZDr. Sohail Zahid

    Dr. Sohail Zahid

    Cardiology · Preventive Cardiology
    Johns Hopkins Hospital
    sohail
    Baltimore, MD, USA